September 08th, 2023

Smith & Wesson Brands, Inc. (Nasdaq: SWBI), a firearms manufacturer, posted first-quarter fiscal 2024 earnings of $0.13 per share, exceeding the consensus EPS estimate of $0.05. The company's quarterly sales reached $114.20 million, surpassing analys. Read more

September 07th, 2023

Science Applications International Corporation (NYSE: SAIC) reported second-quarter fiscal 2024 earnings of $2.05 per share, surpassing the consensus EPS estimate of $1.62. The company's quarterly sales amounted to $1.78 billion, slightly exceeding a. Read more

September 07th, 2023

GameStop Corp. (NYSE: GME) reported a second-quarter fiscal 2023 loss of $(0.03) per share, surpassing the consensus estimate loss of $(0.14). Quarterly sales for the company reached $1.164 billion, slightly exceeding analysts' projected revenue of $. Read more

September 06th, 2023

System1, Inc. (NYSE: SST) said that it has received a non-binding acquisition offer from Just Develop It Limited for Total Security Limited, a System1 company.  The proposal includes $240 million in cash, the assumption of potential earnout p. Read more

September 06th, 2023

GitLab Inc. (Nasdaq: GTLB) reported second-quarter fiscal 2024 earnings of $0.01 per share, surpassing the consensus estimate loss of $(0.03). The company's quarterly sales amounted to $139.58 million, exceeding analysts' projected revenue of $129.67. Read more

September 05th, 2023

America's Car-Mart, Inc. (Nasdaq: CRMT), an automotive retail company, posted first-quarter fiscal 2024 earnings of $0.63 per share, falling short of the consensus EPS estimate of $0.98. Quarterly sales for the company reached $368.00 million, slight. Read more

September 05th, 2023

Tesla, Inc. (Nasdaq: TSLA), a leading electric vehicle and clean energy company, has been granted two new patents by the United States Patent and Trademark Office (USPTO): - Patent No. US-11749842-B2, titled "Cell with a tabless electrode" and; . Read more

September 04th, 2023

Seagen Inc. (Nasdaq: SGEN) and Genmab A/S (Nasdaq: GMAB) have reported a significant breakthrough in the Phase 3 innovaTV 301 global trial for recurrent or metastatic cervical cancer. Patients treated with TIVDAK (tisotumab vedotin-tftv) showed an im. Read more

September 04th, 2023

Some companies poised to unveil their financial results on Wednesday, September 6, include: Phreesia, Inc. (NYSE: PHR), a healthcare technology company, is expected to announce its fiscal second quarter 2024 financial results after the market clos. Read more

September 04th, 2023

XPeng Inc. (NYSE: XPEV), a Chinese electric vehicle manufacturer, announced that it will enter into the highly competitive German automotive market in 2024. The company plans to kickstart its presence with the introduction of the XPENG P7 sports seda. Read more